Evidence brief · Supplement
Aniracetam for Cognition / mood
Evidence grade D — Mostly preclinical
- Overall grade
- Grade D
- Last revised
- 1
- graded outcome
- 0
- references listed
Assembled by the app from other entries in this library. It adds no evidence of its own — follow the links to the entries it draws on.
1 at grade D — 1 graded row
What is known
Each outcome with its grade (how strong the evidence is, A to D), the size of the effect where the entry records one, and how often studies agree.
- Cognition / moodEvidence grade D
Mostly preclinical
Triviallow
What is uncertain
Read off the same rows as above. Nothing here is added that the entry does not itself record.
- Thin evidence: Cognition / mood (grade D).
The evidence in words
The verdict
For cognition / mood, Aniracetam earns evidence grade D (trivial effect, low consistency) — the evidence does not support the claim. Mostly preclinical
How it might work
It modulates AMPA glutamate receptors and cholinergic signaling.
How to use it
Safety & cautions
Generally tolerated; take with fat. Legally grey as a supplement.
Bottom line
An anecdotally popular racetam with little rigorous human evidence, especially in healthy people.
Goes with
- AniracetamRead the full Aniracetam monographEvidence grade D
Related reading
Entries that share this one's tags or conditions.
- Aniracetam: side effects, safety & interactionsGenerally tolerated; take with fat. Legally grey as a supplement.Evidence grade D
- CBD (Cannabidiol) for AnxietyEvidence grade B — Higher dosesEvidence grade B
- DMAE for Cognition / moodEvidence grade D — MixedEvidence grade D
- Inositol (Myo-Inositol) for AnxietyEvidence grade C — High dosesEvidence grade C
Sources
This entry lists no references of its own — it is assembled from the entries it links to, whose sources are on their pages.
Last revised . A grade is this entry's reading of the evidence, not medical advice.